Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Chronic bronchitis; Chronic obstructive pulmonary disease; Emphysema
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 25 Jan 2013 Planned End Date changed from 1 Sep 2011 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.